Michael Genovese, M.D., J.D., chief medical officer for Acadia Healthcare, published a guest column in the Murfreesboro Post that discussed why it is so critical for individuals to have access to dual diagnosis treatment that addresses both mental illnesses and substance use disorders. In his column, Dr. Genovese shined a light on how self-medicating can closely tie addiction to mental health disorders, and he explored how living with a substance use disorder can lead to the development of a mental illness and vice versa. Dr. Genovese also shared that, to enhance accessibility to dual diagnosis treatment, Acadia Healthcare has partnered with Ascension Saint Thomas in Nashville to develop a free-standing psychiatric hospital slated to open in 2020 that will offer mental illness and addiction treatment for individuals and families. Through strategic partnerships and greater education and awareness of dual diagnosis concerns, more people can get the help they need.
Recent Posts
- Acadia and Geisinger Name Kelly Ankenbrand CEO of Geisinger Behavioral Health Center Northeast
- Acadia Healthcare Breaks Ground for Agave Ridge Behavioral Hospital
- Acadia Enters Partnership with UNC Center for the Business of Health
- Bronson and Acadia name Deb Rozewicz as CEO of Bronson Behavioral Health Hospital
- Acadia Names Laura Groschen Company’s New Chief Information Officer
Archives
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- September 2022
- July 2022
- June 2022
- April 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- December 2020
- October 2020
- September 2020
- July 2020
- June 2020
- April 2020
- November 2019
- August 2019
- July 2019
- June 2019